Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04169230
Other study ID # Acute_Citalopram
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 11, 2019
Est. completion date September 2020

Study information

Verified date November 2019
Source University of Oxford
Contact Catherine Hobbs, MSc
Phone 01865618335
Email c.hobbs@bath.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is investigating the effect of an acute dose of citalopram on emotional processing about the self. Using a parallel-group double-blind design, participants will be randomised to receive either an acute dose of citalopram or placebo. Participants will then complete a number of widely used computer-based cognitive tasks measuring emotional processing biases towards the self.

This study has also been registered on OSF: https://osf.io/nhjvs/?view_only=b39c49bddfd543b99b627dc992e49b45


Description:

Antidepressants are thought to operate by changing the way patients process emotional information. After a single dose of citalopram or fluoxetine healthy volunteers have been found to display an increased recognition of happy facial expressions and a reduced recognition of sad faces, in the absence of changes in mood. Studies using depressed participants have produced similar results. However, there has been comparatively little research on changes in emotional processing biases about the self following antidepressant administration. Sense of self has been proposed as fundamental for mental health, with self-schemas acting as a focus through which valence and reward influenced perception, memory and decision-making. Antidepressants may increase learning of positive information about the self, potentially remediating negative self-schema and subsequently reducing depression symptoms.

In this study, the investigators aim to examine whether acute administration of citalopram is associated with an increase in positive emotional learning biases about the self. Using a parallel-group double-blind design, participants will be randomised to receive either an acute dose of citalopram or placebo. Participants will then complete a number of widely used computer-based cognitive tasks measuring emotional processing biases. Identifying early changes in cognition and behaviour following antidepressant treatment will increase our knowledge of how antidepressants operate, and provide putative targets to identify early response to antidepressants.

This study has also been registered on OSF: https://osf.io/nhjvs/?view_only=b39c49bddfd543b99b627dc992e49b45

Starting from the 8th November 2019 an additional task (the Oxford Cognition Stress Task (OCST)) was included in the test battery. This task has been developed by the Psychopharmacology and Emotion Research Laboratory (PERL), Department of Psychiatry, University of Oxford. This is an acute psychosocial stress induction paradigm, comprised of computerised cognitive tasks with an induced failure component. An algorithm varies task timing/difficulty to be just beyond participants' ability, accompanied by aversive feedback. The OCST induces mild, transient increases in stress and arousal, as indexed by heart rate, skin conductance, salivary cortisol and self-reported subjective state measures. Data for this task will be collected, analysed and published by PERL and will not be included in any publications relating to the previous registration for this study. The OCST task has been included at the end of the test battery and is therefore not expected to influence data relating to any self-report measures or tasks outlined in the previous registration

This section of the study has been registered separately on ClinicalTrials.gov (titled 'Citalopram and Stress Reactivity') to reflect the separate research questions and study team involvement.


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date September 2020
Est. primary completion date September 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Male or Female

- Aged 18 -45 years

- Fluent in written and spoken English at a sufficient level to understand and complete the tasks

- Body Mass Index (BMI) 18-30

- Participant is willing and able to give informed consent for participation in the study

- Not currently taking any regular medications (expect the contraceptive pill)

Exclusion Criteria:

- Any past or current Axis 1 DSM-V psychiatric disorder

- Current use of psychoactive medication (except the contraceptive pill, the Depo-Provera injection or the progesterone implant)

- Current or past history of drug or alcohol dependency

- History of current significant neurological condition (e.g. epilepsy)

- Known hypersensitivity to the study drug

- Currently pregnant or breast feeding

- Previous participation in a study that uses the same or similar computer tasks as those used in the present study

- Previous participation in a study that involves the use of a medication within the last three months

- Significant medical condition

- Smokers consuming > 5 cigarettes per day

- Individuals consuming > 6 caffeinated drinks per day

- Lactose Intolerance (due to the study involving administration of a lactose placebo tablet)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Citalopram
Single dose administration of citalopram (20mg)
Placebo oral tablet
Single dose administration lactose placebo tablet

Locations

Country Name City State
United Kingdom University of Oxford Oxford

Sponsors (2)

Lead Sponsor Collaborator
University of Oxford University of Bath

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Social Evaluation Learning Task: Bias Scores An overall index of positive or negative bias will be calculated for each referential condition (self, friend, stranger) using errors to criterion (the number of errors made before 8 rule-congruent responses). Bias is calculated by subtracting errors to criterion made when learning the dislike rule from errors to criterion made when learning the like rule. A positive value indicates a negative bias, as fewer errors are made learning the dislike rule compared to the like rule. Conversely, a negative value indicates a positive bias, as fewer errors are made learning the like rule compared to the dislike rule. The minimum possible value is - 24 (complete bias towards being liked), and the maximum value is + 24 (complete bias towards being disliked). Day 1: 3-5.5 hours post drug administration
Primary Associative Learning Task: Reaction Times (ms) Mean reaction times will be calculated for each referential condition (self, friend, stranger), reward condition (high, medium, low) and valence condition (positive, neutral, negative) for each respective task. Day 1: 3-5.5 hours post drug administration
Primary Associative Learning Task: Accuracy (% correct) Mean accuracy will be calculated for each referential condition (self, friend, stranger), reward condition (high, medium, low) and valence condition (positive, neutral, negative) for each respective task. Day 1: 3-5.5 hours post drug administration
Primary Self-Esteem Go/No-Go Association Task: d' Discriminative accuracy (d') will be calculated through applying Z-score transformations, and subtracting hit z-scores from false alarm z-scores. Z-scores are adjusted by adding or subtracting .005 if hit or false-alarm rates are 0 or 1. d' -values can then be compared for each possible categorical combination to examine implicit self-biases. Day 1: 3-5.5 hours post drug administration
Secondary Prisoner's Dilemma: Cooperative Behaviours (%) The main outcome for this task is the proportion of rounds on which participants choose to cooperate. The conditional probability of cooperating will be calculated according to the proportion of rounds on which participants cooperated following each of the four possible outcomes. Day 1: 3-5.5 hours post drug administration
Secondary Prisoner's Dilemma: Reaction Times (ms) Reaction times for cooperation versus non-cooperation choices will be calculated. Day 1: 3-5.5 hours post drug administration
Secondary Emotional Categorisation and Recall: Number of words categorised The mean number of positive and negative words categorised as describing or not describing the participant/the other will be recorded. Day 1: 3-5.5 hours post drug administration
Secondary Emotional Categorisation and Recall: Hits Mean hits will be collected for each referential condition and valence. Day 1: 3-5.5 hours post drug administration
Secondary Emotional Categorisation and Recall: False Alarms Mean alse intrusions will be collected for each referential condition and valence. Day 1: 3-5.5 hours post drug administration
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A

External Links